LLY ELI LILLY & Co

  1. Stocks
  2. Healthcare
  3. NYSE: LLY

Price (delayed)

$335.87

Market cap

$319.18B

P/E Ratio

48.47

Dividend/share

$4.07

EPS

$6.93

Enterprise value

$333.35B

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded ...

Highlights
The equity has increased by 19% year-on-year and by 6% since the previous quarter
The EPS has increased by 13% YoY and by 3.7% QoQ
ELI LILLY's debt has decreased by 3.8% YoY but it has increased by 2.2% from the previous quarter
The quick ratio has declined by 21% year-on-year and by 11% since the previous quarter
The P/E is 10% above the 5-year quarterly average of 44.0
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.lilly.com/
Peers: BMY MRK JNJ PFE

Key stats

What are the main financial stats of LLY
Market
Shares outstanding
950.3M
Market cap
$319.18B
Enterprise value
$333.35B
Valuations
Price to earnings (P/E)
48.47
Price to book (P/B)
29.97
Price to sales (P/S)
10.61
EV/EBIT
48.98
EV/EBITDA
40.02
EV/Sales
11.68
Earnings
Revenue
$28.54B
EBIT
$6.81B
EBITDA
$8.33B
Free cash flow
$5.23B
Per share
EPS
$6.93
Free cash flow per share
$5.8
Book value per share
$11.21
Revenue per share
$31.65
TBVPS
$42.37
Balance sheet
Total assets
$49.49B
Total liabilities
$38.71B
Debt
$16.24B
Equity
$10.65B
Working capital
$896.3M
Liquidity
Debt to equity
1.52
Current ratio
1.05
Quick ratio
0.63
Net debt/EBITDA
1.7
Margins
EBITDA margin
29.2%
Gross margin
76.8%
Net margin
21.9%
Operating margin
23.8%
Efficiency
Return on assets
13.1%
Return on equity
64.7%
Return on invested capital
19.5%
Return on capital employed
21%
Return on sales
23.8%
Dividend
Dividend yield
1.21%
DPS
$4.07
Payout ratio
58.7%

LLY stock price

How has the ELI LILLY stock price performed over time
Intraday
-0.53%
1 week
1.48%
1 month
7.92%
1 year
16.46%
YTD
-8.19%
QTD
-8.19%

Financial performance

How have ELI LILLY's revenue and profit performed over time
Revenue
$28.54B
Gross profit
$21.91B
Operating income
$6.81B
Net income
$6.24B
Gross margin
76.8%
Net margin
21.9%
The net income has grown by 12% YoY and by 3.5% from the previous quarter
LLY's operating income is up by 11% year-on-year and by 3.9% since the previous quarter
ELI LILLY's net margin has increased by 11% YoY and by 6% from the previous quarter
ELI LILLY's operating margin has increased by 10% YoY and by 6% from the previous quarter

Growth

What is ELI LILLY's growth rate over time

Valuation

What is ELI LILLY stock price valuation
P/E
48.47
P/B
29.97
P/S
10.61
EV/EBIT
48.98
EV/EBITDA
40.02
EV/Sales
11.68
The EPS has increased by 13% YoY and by 3.7% QoQ
The P/E is 10% above the 5-year quarterly average of 44.0
The equity has increased by 19% year-on-year and by 6% since the previous quarter
LLY's P/B is 7% below its last 4 quarters average of 32.1
The stock's price to sales (P/S) is 56% more than its 5-year quarterly average of 6.8 and 5% more than its last 4 quarters average of 10.1
ELI LILLY's revenue has decreased by 2.4% from the previous quarter

Efficiency

How efficient is ELI LILLY business performance
The company's return on equity fell by 13% YoY
The ROA has grown by 12% YoY and by 3.1% from the previous quarter
The ROIC has grown by 12% YoY and by 4.3% from the previous quarter
The ROS has increased by 10% YoY and by 6% QoQ

Dividends

What is LLY's dividend history
Dividend details
DPS
$4.07
Dividend yield
1.21%
Payout ratio
58.7%
Recent dividends

Financial health

How did ELI LILLY financials performed over time
LLY's total assets is 28% greater than its total liabilities
The quick ratio has declined by 21% year-on-year and by 11% since the previous quarter
ELI LILLY's current ratio has decreased by 15% YoY and by 7% from the previous quarter
ELI LILLY's debt is 52% more than its equity
The company's debt to equity fell by 19% YoY and by 3.8% QoQ
The equity has increased by 19% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.